July 11th, 2011 | tysabri
TysabriLawsuitResources.com Provides Tysabri Victims with Information Regarding Tysabri FDA Warnings and Legal Resources
New York, NY – July 11, 2011 – Chaffin Luhana LLP has released a new website for patients who have been adversely affected by Tysabri side effects. The goal of the Tysabri lawsuit website, http://tysabrilawsuitresources.com, is to educate those individuals who believe they have been harmed or critically injured while taking Tysabri by providing detailed facts regarding Tysabri side effects to help determine if they are eligible for a Tysabri lawsuit. In addition, the site explains the kinds of legal recourse that victims can utilize to protect their rights and provides details on the Tysabri FDA Warnings.
Approved by the Food and Drug Administration (FDA) in 2004 and first sold under the name Antegren, Tysabri is both potent and effective; even so, Tysabri may cause patients to develop a serious viral brain disease known as progressive multifocal leukoencephalopathy (PML). In fact, Tysabri’s current packaging notes that approximately 1.16 of every 1,000 Tysabri patients will develop PML. Chaffin Luhana’s Tysabri lawsuit website will help in educating consumers on Tysabri PML side effects and by providing a resource to individuals who believe they now are enduring undisclosed Tysabri side effects.
If you or someone close to you is potentially suffering from Tysabri side effects, including PML, you may be entitled to compensation, and Chaffin Luhana can help. Contact Chaffin Luhana today by visiting http://www.chaffinluhana.com, or call toll-free at 1-888-480-1123 for a complimentary case evaluation.
No related posts; find what you're looking for: